CClinicalTrials.gg
CompletedNCT06813066Updated May 22, 2026

Simulating Psychotherapeutic Sessions With Generative Artificial Intelligence

An interventional study of High Levels of Common Therapeutic Factors and Low Levels of Common Therapeutic Factors in Mental Disorder, sponsored by University Hospital, Basel, Switzerland. Completed at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-22.

Sponsored by University Hospital, Basel, Switzerland · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
520
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The study assesses the potential of using computational models, specifically large language models, to simulate psychotherapeutic sessions, aiming to improve therapy outcomes and advance therapist training through innovative technology.

Read the detailed description

Health research has evolved significantly, increasingly incorporating computational models that improve our understanding and effectiveness of medical interventions. This shift from traditional to computational methods represents a major advancement in medical research, offering a more sustainable and innovative approach for conceptual advances and therapeutic discovery. In silico models, based on scientific simulation, use computational algorithms to mimic real-world systems or processes. This virtual environment allows researchers to explore phenomena impractical, unethical, dangerous, expensive, or impossible to study otherwise.

Psychotherapy is widely acknowledged as a primary treatment for a variety of mental health conditions, from depression and anxiety to personality disorders, offering significant pathways to recovery and improved quality of life. Yet current methods have shown limited effectiveness, prompting a need for innovative research approaches. In silico psychotherapy research leverages computational simulations, large language models (LLMs), and generative artificial intelligence to explore and refine psychotherapeutic interventions. By simulating human-like conversations, this approach provides insights into therapy dynamics and holds promise for revolutionizing therapist training and expanding treatment techniques.

This study aims to establish a proof-of-concept for simulating psychotherapeutic sessions using LLMs, focusing specifically on motivational interviewing. It involves the simulation of 512 psychotherapy sessions using LLMs as well as 8 real-world psychotherapy transcripts. By modeling human interactions, the study seeks to enhance healthcare delivery, therapist training, and personalized psychotherapy.

02

Conditions studied

  • Mental Disorder

Browse trials for

Keywords

  • In silico Psychotherapy
  • Artificial intelligence (AI) applications
  • Motivational Interviewing
03

In context

Mental Disorders

2,107 studies on the registry are indexed under Mental Disorders; 416 are open to participants now.

This study's enrollment of 520 is above the median of 94 across 1,574 interventional studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

University Hospital, Basel, Switzerland is the lead sponsor of 968 studies on the registry; 191 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Simulation of psychotherapy sessions of conversations between an adult person presenting with a mental or behavioral health problem and a psychotherapist using large language models and 8 real-world transcripts

Exclusion criteria

Exclusion Criteria:

  • Simulation protocols with severe simulation errors
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
520 participants (actual)

Study arms

  • Experimental
    High Levels of Common Therapeutic Factors

    In this group, the patient-large language model (LLM) interacted with a therapist-LLM prompted to exhibit high levels of positive common factors.

    Behavioral: High Levels of Common Therapeutic Factors

  • Experimental
    Low Levels of Common Therapeutic Factors

    In this group, the patient-large language model (LLM) interacted with a therapist-LLM prompted to exhibit low levels of positive common factors.

    Behavioral: Low Levels of Common Therapeutic Factors

  • Other
    Transcripts of real intervention sessions

    This group consists of published transcripts of real intervention sessions, in which motivational interview techniques have been applied.

    Behavioral: Standard motivational interviewing

Interventions

  • BehavioralHigh Levels of Common Therapeutic Factors

    The therapist large language model (LLM) is designed to show high levels of empathy, warmth, and genuineness. This setup aims to create a supportive and trusting therapeutic environment to improve patient engagement. High levels of these positive factors are linked to better psychotherapy outcomes and a stronger therapist-patient relationship.

  • BehavioralLow Levels of Common Therapeutic Factors

    The therapist LLM for this group is designed to show low levels of empathy, warmth, and genuineness. This setup aims to examine how a less supportive and empathetic therapist affects psychotherapy sessions. Lower levels of these positive behaviors can lead to reduced patient engagement and a weaker therapist-patient relationship, potentially hindering therapy outcomes.

  • BehavioralStandard motivational interviewing

    Motivational interviewing techniques as applied during the sessions on which the transcripts are based.

06

What researchers measure

Primary outcomes

  1. Simulation's Accuracy in generating Psychotherapeutic Dialogues

    Assessment of the simulation's ability to accurately produce psychotherapeutic dialogues that adhere to the principles and techniques of motivational interviewing (MI), as determined by the average global scores of the Motivational Interviewing Treatment Integrity (MITI) code 4.2. The MITI code 4.2 includes various subscales, such as empathy and MI spirit, each scored on a scale from 1 to 5, with lower scores suggesting a need for improvement in MI delivery, while higher scores reflect stronger therapeutic skills and better patient outcomes.

    Time frame: 12 months

Secondary outcomes

  1. Number of Errors/Deviations

    The number of errors or deviations from expected psychotherapeutic practices is counted, providing a quantitative measure of simulation quality. This measure also serves as exclusion criteria from any other assessment.

    Time frame: 12 months

  2. Metric of Verbal Content (Therapist)

    Assessment of the text metrics of the therapist, based on the number of sentences, words, syllables, characters, and lexical diversity.

    Time frame: 12 months

  3. Metric of Verbal Content (Patient)

    Assessment of the text metrics of the patient, based on the number of sentences, words, syllables, characters, and lexical diversity.

    Time frame: 12 months

  4. Turn-takings

    Assessment of the turn-takings, based on the number of exchanges between the therapist and patient within a session, indicating the dynamic interaction flow.

    Time frame: 12 months

  5. Improvement of Patient

    Improvement of the patient is evaluated using an an observer-rated, circularly framed version of the Importance and Confidence Rulers, measuring the simulated patient's psychotherapeutic progress on a circular scale from 0 to 10. Lower scores indicate lower perceived importance or confidence, while higher scores suggest greater perceived importance or confidence in making the change.

    Time frame: 12 months

  6. Credibility of Patient Behavior

    The credibility of the patient's behavior is estimated using a 0 to 10 scale indicating how likely the evaluator found that the participants are real humans or simulations, offering insight into the perceived authenticity of the simulated interactions. The credibility of the 8 real-world transcripts served as a comparison baseline/benchmark for this evaluation. Lower scores indicate lower authenticity of the patient large-language model's (LLM's) simulated behavior, while higher scores suggest higher authenticity of the patient LLM's simulated behavior.

    Time frame: 12 months

  7. Credibility of Therapist Behavior

    The credibility of the therapist's behavior is estimated using a 0 to 10 scale indicating how likely the evaluator found that the participants are real humans or simulations, offering insight into the perceived authenticity of the simulated interactions. The credibility of the 8 real-world transcripts served as a comparison baseline/benchmark for this evaluation. Lower scores indicate lower authenticity of the therapist large-language model's (LLM's) simulated behavior, while higher scores suggest higher authenticity of the therapist LLM's simulated behavior.

    Time frame: 12 months

  8. Manipulation Check

    The implemented level of psychotherapeutic common factors by the therapist-LLM is approximated using the Therapist Empathy Scale (TES) as rough manipulation checks. The TES rates the therapist's ability to understand and share a patient's feelings on a scale from 1 to 7. Higher scores indicate greater empathy, reflecting a stronger connection and understanding of the patient's emotions, while lower scores suggest less empathy.

    Time frame: 12 months

  9. Manipulation Check

    The implemented level of psychotherapeutic common factors by the therapist-LLM is approximated using the Working Alliance Inventory Short Observer form (WAI-S-O) as rough manipulation checks. The Working Alliance Inventory uses 12 items evaluating the perceived therapeutic alliance between the patient and the therapist on a scale of 1 to 7.

    Time frame: 12 months

07

Study locations

1 site
  • University Hospital Basel
    Basel, 4031, Switzerland
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06813066
Lead sponsor
University Hospital, Basel, Switzerland
Collaborators
University of Trier, RWTH Aachen University, University of Basel
Responsible party
Sponsor
First posted
Feb 6, 2025
Start date
Feb 1, 2025
Primary completion
Aug 31, 2025
Completion
Aug 31, 2025
Last update
May 22, 2026

Study contacts

Gunther Meinlschmidt, Prof. Dr.
principal investigator · University Hospital and University of Basel

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion